Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-032865

CEO and President gave up 48,659 shares (to pay taxes)

  • CEO and President acquired 207,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KLEMP WALTER V CEO and President 2026-10-15 Option exercise +207,500 771,840 D
KLEMP WALTER V CEO and President 2026-10-15 Shares withheld for taxes −48,659 $0.37 $18,009 723,181 D
Derivatives
KLEMP WALTER V CEO and President 2026-10-15 Grant or award · Options (right to buy) +415,000 2,341,335 D
KLEMP WALTER V CEO and President 2026-10-15 Grant or award · Restricted Stock Units +415,000 2,756,335 D
KLEMP WALTER V CEO and President 2026-10-15 Option exercise · Restricted Stock Units −207,500 2,548,335 D
Loading xslF345X06/rdgdoc.xml…